Bausch Health Companies Inc. clinical trials

The registry lists 534 studies whose lead sponsor is Bausch Health Companies Inc. or one of 16 companies grouped under it. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 534. Browse all 534 →

• Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)RecruitingNCT07428538Phase 3

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FCRecruitingNCT07723924Phase 2

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative ColitisNot yet recruitingNCT05976802Phase 4

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive DisorderNot yet recruitingNCT02129751Phase 4

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency TreatmentRecruitingNCT07187297Not applicable

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution TrialNot yet recruitingNCT07778888Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute DiarrheaRecruitingNCT07285785Phase 4

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoRecruitingNCT07524946Phase 4

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract SurgeryRecruitingNCT06246136Not applicable

  Sponsor listed in the registry: Elios Vision, Inc. · First submitted before Elios Vision, Inc. became part of Bausch Health Companies Inc.

• A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic AstigmatismNot yet recruitingNCT07377474Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• IC-8 Apthera IOL New Enrollment Post Approval StudyRecruitingNCT06060041

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe PsoriasisEnrolling by invitationNCT03254667

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative ColitisRecruitingNCT04314375Phase 4

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2RecruitingNCT06997003Not applicable

  Sponsor listed in the registry: Bausch & Lomb GmbH · First submitted after Bausch & Lomb GmbH became part of Bausch Health Companies Inc.

• A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in ChildrenRecruitingNCT06305663Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive KeratectomyNot yet recruitingNCT06618547Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Post-Approval Study With the KAMRA InlayNot yet recruitingNCT03173664

  Sponsor listed in the registry: AcuFocus, Inc. · First submitted before AcuFocus, Inc. became part of Bausch Health Companies Inc.

• A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive KeratectomyCompletedNCT07412496Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Safety and Efficacy of IDP-118 in Participants With Plaque PsoriasisCompletedNCT02462122Phase 3

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• The Plecanatide Irritable Bowel Syndrome With Constipation Safety and Efficacy Study (IBS-C)CompletedNCT02387359Phase 3

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Participants With Acne VulgarisCompletedNCT03664752Phase 3

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Participants With Acne VulgarisCompletedNCT02932306Phase 3

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Safety and Efficacy of IDP-122 in Participants With Plaque PsoriasisCompletedNCT02515097Phase 3

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Revive Toric RWE StudyWithdrawnNCT06785194

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without AstigmatismCompletedNCT05264623Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisActive, not recruitingNCT03987763Phase 4

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work ProductivityActive, not recruitingNCT05132231

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• 1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for AstigmatismCompletedNCT05320042Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial ParticipantsCompletedNCT07717918Phase 1

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne VulgarisCompletedNCT07205107

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin ResurfacingActive, not recruitingNCT07214272Not applicable

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• 1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact LensesCompletedNCT06053736Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact LensesCompletedNCT05129488Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• 1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for PresbyopiaCompletedNCT05325931Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 LensesCompletedNCT04840563Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT07168902Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye DiseaseCompletedNCT07128628Phase 2

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333015Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive AccuracyCompletedNCT06346340Phase 4

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Excimer Laser Trabeculostomy Glaucoma Treatment StudyCompletedNCT04899063Not applicable

  Sponsor listed in the registry: Elios Vision, Inc. · First submitted before Elios Vision, Inc. became part of Bausch Health Companies Inc.

• Safety and Feasibility of the ELIOS System in POAG PatientsCompletedNCT05999006Not applicable

  Sponsor listed in the registry: Elios Vision, Inc. · First submitted before Elios Vision, Inc. became part of Bausch Health Companies Inc.

• A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06594185Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular RednessCompletedNCT06803654Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) LensTerminatedNCT06479148Not applicable

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Post-Market Clinical Follow-Up on Safety and Performance of the Ophthalmic Viscoelastic Devices Eyefill SC and Eyefill MBCompletedNCT06767917Not applicable

  Sponsor listed in the registry: Bausch & Lomb GmbH · First submitted after Bausch & Lomb GmbH became part of Bausch Health Companies Inc.

• A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisCompletedNCT03988439Phase 4

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy VolunteersActive, not recruitingNCT06978244Phase 1

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedNCT03596905Phase 2

  Sponsor listed in the registry: Bausch Health Americas, Inc. · First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc.

• A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens WearCompletedNCT07054606Phase 4

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.

• A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye DiseaseWithdrawnNCT07111013Phase 3

  Sponsor listed in the registry: Bausch & Lomb Incorporated · First submitted after Bausch & Lomb Incorporated became part of Bausch Health Companies Inc.